CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY - USD ($) $ in Thousands	Total	Series A Preferred	Series B1 Preferred Stock	Common Stock	Common Stock Series A Preferred	Common Stock Series B1 Preferred Stock	Preferred stock Series A Preferred	Additional Paid-In Capital	Additional Paid-In Capital Series B1 Preferred Stock	Retained Earnings	Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2021				63,288,000			386,000
Beginning balance at Dec. 31, 2021	$ 30,066			$ 63			$ 0	$ 138,620		$ (110,614)	$ 1,997
Increase (Decrease) in Stockholders' Equity
Exercise of options/B1 warrants (in shares)				60,000		1,113,000
Exercise of options/ B1 warrants	76		$ 0	$ 0		$ 1		76	$ (1)
Stock based compensation expense	250							250
Conversion of Series A Preferred stock to common (in shares)					5,000		(5,000)
Conversion of Series A Preferred stock to common		$ 0
Equity component of the convertible note issuance, net	78,789							78,789
Accretion of redeemable non-controlling interest to redemption value	(422)									(422)
Net income (loss)	(809)									(4,548)	3,739
Less: amount attributable to redeemable non-controlling interest	(3,769)										(3,769)
Ending balance (in shares) at Mar. 31, 2022				64,466,000			381,000
Ending balance at Mar. 31, 2022	104,181			$ 64			$ 0	217,734		(115,584)	1,967
Beginning balance (in shares) at Dec. 31, 2022				75,670,000			0
Beginning balance at Dec. 31, 2022	165,420			$ 76			$ 0	279,552		(115,893)	1,685
Increase (Decrease) in Stockholders' Equity
Exercise of options/B1 warrants (in shares)				166,000
Exercise of options/ B1 warrants	209							209
Stock based compensation expense	365							365
Non controlling shareholder contribution	980										980
Net income (loss)	53,813									53,863	(50)
Ending balance (in shares) at Mar. 31, 2023				75,836,000			0
Ending balance at Mar. 31, 2023	$ 220,787			$ 76			$ 0	$ 280,126		$ (62,030)	$ 2,615